ArticleNature communications2025
Streamlined construction of boron-stereogenic BODIPY library for near-infrared bioimaging.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Cobalt-Catalyzed Asymmetric Construction of Boron Stereocenters With C-N Axial Chirality.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Construction of boron-stereogenic BODIPYs through organo-catalyzed enantioselective formal C(spNature communications · 2026Article
- Deprotonation- and TICT-triggered ultra-large Stokes shift of aqueous NIR-emissive hydroxylstryryl-pyridinium derivatives.RSC advances · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Chirality is fundamental to molecular recognition, critically influencing pharmaceutical interactions, biomolecular sensing, and chiroptical device performance. While chiroptical luminophores hold transformative potential for optoelectronic innovation and precision bioimaging, their rational engineering remains constrained by synthetic limitations. Here, we report a streamlined and programmable asymmetric synthesis platform enabling systematic construction of boron-stereogenic boron dipyrromethene (BODIPYs) with near-infrared (NIR) chiroptical activity. This approach enables precise functionalization of prochiral BODIPYs via catalytic enantioselective cross-coupling, affording increased π-conjugated dyes with excellent enantiomeric excess and tunable photophysical properties. Further study demonstrates that molecular chirality plays a critical role in cellular recognition, as our chiral BODIPY dyes exhibit enantioselective uptake and distinct subcellular localization in cells. When formulated as nanoparticles, these dyes enable high-resolution NIR-II vascular imaging. This work not only establishes boron-centered stereogenicity as a design paradigm for advanced chiroptical bioimaging probes but also unveils dimensions in chiral organoboron chemistry with implications spanning from targeted therapeutics to chiral photonics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.